Prestige Consumer Healthcare Inc. (PBH): Price and Financial Metrics

Prestige Consumer Healthcare Inc. (PBH): $60.43

0.05 (+0.08%)

POWR Rating

Component Grades














  • PBH scores best on the Stability dimension, with a Stability rank ahead of 92.04% of US stocks.
  • PBH's strongest trending metric is Stability; it's been moving up over the last 178 days.
  • PBH ranks lowest in Momentum; there it ranks in the 12th percentile.

PBH Stock Summary

  • With a one year PEG ratio of 149.44, PRESTIGE CONSUMER HEALTHCARE INC is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 84.77% of US stocks.
  • The ratio of debt to operating expenses for PRESTIGE CONSUMER HEALTHCARE INC is higher than it is for about 82.86% of US stocks.
  • In terms of volatility of its share price, PBH is more volatile than merely 5.08% of stocks we're observing.
  • If you're looking for stocks that are quantitatively similar to PRESTIGE CONSUMER HEALTHCARE INC, a group of peers worth examining would be TWNK, ACT, WSC, SON, and DAR.
  • Visit PBH's SEC page to see the company's official filings. To visit the company's web site, go to

PBH Valuation Summary

  • In comparison to the median Healthcare stock, PBH's price/sales ratio is 43.75% lower, now standing at 2.7.
  • PBH's price/sales ratio has moved down 9.7 over the prior 217 months.

Below are key valuation metrics over time for PBH.

Stock Date P/S P/B P/E EV/EBIT
PBH 2022-11-25 2.7 1.8 14.3 13.4
PBH 2022-11-23 2.7 1.8 14.2 13.3
PBH 2022-11-22 2.7 1.9 14.5 13.5
PBH 2022-11-21 2.7 1.8 14.1 13.3
PBH 2022-11-18 2.7 1.8 14.2 13.3
PBH 2022-11-17 2.6 1.8 13.9 13.1

PBH Growth Metrics

    The 3 year revenue growth rate now stands at 11.38%.
  • Its 5 year net cashflow from operations growth rate is now at 21.81%.
  • The 2 year net cashflow from operations growth rate now stands at 19.71%.
PBH's revenue has moved up $69,152,000 over the prior 52 months.

The table below shows PBH's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 1,107.738 245.21 208.596
2022-06-30 1,094.69 248.864 202.898
2022-03-31 1,086.812 259.922 205.381
2021-12-31 1,057.637 255.883 188.809
2021-09-30 1,021.955 238.813 179.467
2021-06-30 983.152 229.758 178.731

PBH's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • PBH has a Quality Grade of C, ranking ahead of 40.37% of graded US stocks.
  • PBH's asset turnover comes in at 0.283 -- ranking 157th of 682 Pharmaceutical Products stocks.
  • GHSI, KPTI, and CDTX are the stocks whose asset turnover ratios are most correlated with PBH.

The table below shows PBH's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.283 0.582 0.167
2021-03-31 0.274 0.580 0.159
2020-12-31 0.276 0.579 0.161
2020-09-30 0.277 0.576 0.159
2020-06-30 0.276 0.575 0.152
2020-03-31 0.277 0.573 0.145

PBH Price Target

For more insight on analysts targets of PBH, see our PBH price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $63.50 Average Broker Recommendation 1.58 (Moderate Buy)

PBH Stock Price Chart Interactive Chart >

Price chart for PBH

PBH Price/Volume Stats

Current price $60.43 52-week high $63.47
Prev. close $60.38 52-week low $48.51
Day low $59.99 Volume 234,400
Day high $60.66 Avg. volume 266,761
50-day MA $53.87 Dividend yield N/A
200-day MA $55.42 Market Cap 2.99B

Prestige Consumer Healthcare Inc. (PBH) Company Bio

Prestige Brands Holdings markets and distributes brand name over-the-counter health-care and household products throughout the U.S., Canada, Australia, and in certain other international markets. Core brands include Monistat women's health products, Nix lice treatments, Chloraseptic sore throat treatments, Compound W wart treatments, Clear Eyes eye care products, Little Remedies pediatric products, The Doctor's NightGuard dental protector, Efferdent denture care products, Luden's throat drops, Dramamine motion sickness treatments, BC and Goody's headache remedies, Beano gas prevention, Debrox earwax remover, and in Canada, Gaviscon antacid. The company was founded in 1996 and is based in Tarrytown, New York.

PBH Latest News Stream

Event/Time News Detail
Loading, please wait...

PBH Latest Social Stream

Loading social stream, please wait...

View Full PBH Social Stream

Latest PBH News From Around the Web

Below are the latest news stories about PRESTIGE CONSUMER HEALTHCARE INC that investors may wish to consider to help them evaluate PBH as an investment opportunity.

Prestige Consumer Healthcare Second Quarter 2023 Earnings: Beats Expectations

Prestige Consumer Healthcare ( NYSE:PBH ) Second Quarter 2023 Results Key Financial Results Revenue: US$289.3m (up 4.7...

Yahoo | November 9, 2022

Prestige Brands (PBH) Tops Q2 Earnings and Revenue Estimates

Prestige Brands (PBH) delivered earnings and revenue surprises of 2% and 2.24%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | November 3, 2022

Prestige Consumer Healthcare Inc. Reports Second Quarter Results and Reaffirms Outlook for Fiscal 2023

Record Revenue of $289.3 Million in Q2 fiscal 2023 increased 4.7% versus Prior Year and 5.5% excluding CurrencyDiluted EPS of $1.02 for Q2, ahead of expectationsReduced Debt by $35 million in Q2 and Achieved Leverage Ratio of 3.7xReaffirming Full-Year Fiscal 2023 Revenue and Earnings Outlooks TARRYTOWN, N.Y., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its second fiscal quarter ended September 30, 2022. “Our second quarter o

Yahoo | November 3, 2022

Earnings Preview: Prestige Brands (PBH) Q2 Earnings Expected to Decline

Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | October 27, 2022

Prestige Consumer Healthcare Inc. to Release Fiscal 2023 Second Quarter Earnings Results

TARRYTOWN, N.Y., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2023 second quarter earnings release on Thursday, November 3, 2022 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET. To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of

Yahoo | October 4, 2022

Read More 'PBH' Stories Here

PBH Price Returns

1-mo 9.06%
3-mo 19.47%
6-mo 7.13%
1-year 8.07%
3-year 59.99%
5-year 35.38%
YTD -0.36%
2021 73.93%
2020 -13.90%
2019 31.15%
2018 -29.59%
2017 -14.76%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7697 seconds.